tiprankstipranks
Trending News
More News >
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market

Oramed Pharm (ORMP) Income Statement

Compare
525 Followers

Oramed Pharm Income Statement

Last quarter (Q3 2025), Oramed Pharm's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Oramed Pharm's net income was $48.40M. See Oramed Pharm’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.34M$ 2.70M$ 2.70M$ 2.71M
Gross Profit
$ -193.00K$ 1.34M$ 2.70M$ 2.70M$ 2.62M
Operating Expenses
$ 12.78M$ 17.11M$ 43.30M$ 26.93M$ 14.47M
Depreciation and Amortization
$ 193.00K$ 196.00K$ 3.62M$ 77.00K$ 7.00K
EBITDA
$ -14.87M$ 7.32M$ -36.98M$ -25.04M$ -11.31M
Operating Income
$ -12.78M$ -15.77M$ -40.60M$ -24.22M$ -11.76M
Other Income/Expenses
$ -3.14M$ 20.86M$ 2.93M$ 893.00K$ -438.00K
Pretax Income
$ -15.92M$ 5.09M$ -37.66M$ -22.99M$ -11.51M
Net Income
$ -19.10M$ 5.53M$ -37.76M$ -22.24M$ -11.51M
Per Share Metrics
Basic EPS
$ -0.47$ 0.14$ -0.97$ -0.78$ -0.56
Diluted EPS
$ -0.47$ 0.14$ -0.97$ -0.78$ -0.56
Weighted Average Shares Outstanding
40.83M 40.32M 39.00M 28.47M 20.53M
Weighted Average Shares Outstanding (Diluted)
40.83M 40.57M 39.00M 28.47M 20.53M
Currency in USD

Oramed Pharm Earnings and Revenue History